IP Library Granted Patent US 7,214,793
Granted Patent B2
US 7,214,793 · App. 10/533,052 · Granted May 8, 2007

Method of preparing 10H-dibenzo[b,f][11,4]thiazepin-11-one

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,793
App. No.
10/533,052
Granted
May 8, 2007
Kind
B2
Abstract

Disclosed is a method of preparing 10H-dibenzo[b,f][1,4]thiazepin-11-one, including reacting dithiosalicylic acid with 1-chloro-2-nitrobenzene in a basic aqueous solution in the presence or absence of a reducing agent, to prepare 2-(2-nitrophenylsulfuryl)benzoic acid; subjecting the 2-(2-nitrophenylsulfuryl)benzoic acid to nitro group reduction in the presence of hydrogen, a solvent and a heterogeneous metal catalyst, to prepare 2-(2-aminophenylsulfuryl)benzoic acid; and directly cyclizing the 2-(2-aminophenylsulfuryl)benzoic acid in an organic solvent in the presence or absence of an acid catalyst. The method according to the present invention is economical due to the use of the inexpensive starting material, and also environmentally friendly and efficient by minimizing the use of the organic solvent and performing direct cyclization without the activation of carboxylic acid.

Claims (18)

1. A method of preparing 10H-dibenzo[b,f][1,4]thiazepin-11-one represented by Formula 1, comprising the steps of:

(a) reacting dithiosalicylic acid represented by Formula 2 with 1-chloro-2-nitrobenzene in a basic aqueous solution in the presence or absence of a reducing agent, to prepare 2-(2-nitrophenylsulfuryl)benzoic acid represented by Formula 3;

(b) subjecting the 2-(2-nitrophenylsulfuryl)benzoic acid represented by Formula 3 to nitro group reduction in the presence of hydrogen gas, a solvent and a heterogeneous metal catalyst, to prepare 2-(2-aminophenylsulfuryl)benzoic acid represented by Formula 4; and

(c) directly cyclizing the 2-(2-aminophenylsulfuryl)benzoic acid represented by Formula 4 in an organic solvent in the presence or absence of an acid catalyst:

2. The method as defined in claim 1 , wherein the step (a) is performed at 50–100° C., in which 1-chloro-2-nitrobenzene is used in an amount of 2–3 equivalents, based on 1 equivalent of dithiosalicylic acid.

3. The method as defined in claim 1 , wherein a base for use in the basic aqueous solution is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, and sodium bicarbonate, and is used in an amount of 4–5 equivalents.

4. The method as defined in claim 1 , wherein the reducing agent is selected from the group consisting of sodium borohydride, sodium hyposulfite, zinc, magnesium, and hydrazine.

5. The method as defined in claim 1 , wherein the step (b) is performed at 1–200° C. under pressure of 10–1,000 psig for 1–14 hours.

6. The method as defined in claim 1 , wherein the solvent used in the step (b) is selected from the group consisting of water, methyl alcohol, ethyl alcohol, n-propyl alcohol, and iso-propyl alcohol.

7. The method as defined in claim 1 , wherein the 2-(2-nitrophenylsulfuryl)benzoic acid in the step (b) is used in an amount of 1–50 wt %, based on total reactants.

8. The method as defined in claim 1 , wherein the heterogeneous metal catalyst comprises a metal selected from the group consisting of Raney-nickel (Raney-Ni), ruthenium (Ru), palladium (Pd), platinum (Pt), and rhodium (Rh), and is used in an amount of 2–30 wt %, based on the total reactants.

9. The method as defined in claim 1 , wherein the heterogeneous metal catalyst comprises a metal supported to a support, and is used in an amount of 2–30 wt %, based on the total reactants, and

the metal being selected from the group consisting of Raney-nickel (Raney-Ni), ruthenium (Ru), palladium (Pd), platinum (Pt), and rhodium (Rh), and

the support being selected from the group consisting of alumina, silica, zeolite, and molecular sieve.

10. The method as defined in claim 1 , wherein the step (c) is performed at 50–200° C.

11. The method as defined in claim 1 , wherein the acid catalyst is selected from the group consisting of sulfuric acid, phosphoric acid, nitric acid, p-toluene sulfonic acid, and benzene sulfonic acid, and is used in the amount of 0.1–5 wt %, based on the total reactants.

12. The method as defined in claim 1 , wherein the organic solvent in the step (c) is selected from the group consisting of benzene, toluene, and xylene.

13. The method as defined in claim 1 , wherein the 2-(2-aminophenylsulfuryl)benzoic acid is used in an amount of 1–50 wt %, based on the total reactants.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2015
From: SK BIOPHARMACEUTICALS CO., LTD.
To: SK BIOTEK CO., LTD.
Reel/Frame 036528/0866 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2011
From: SK HOLDINGS CO., LTD.
To: SK BIOPHARMACEUTICALS CO., LTD.
Reel/Frame 027006/0600 →
CHANGE OF NAME Recorded Nov 5, 2007
From: SK CORPORATION
To: SK HOLDINGS CO., LTD.
Reel/Frame 020112/0329 →